Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
Dogs share our homes and environments. They grow up with us and grow old with us. And as they age, dogs tend to get many of the same health problems that we do—conditions like obesity, heart problems, cancer, and mental decline. Most of the genes found in dogs are also found in humans. Because we …
A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety of a candidate vaccine, BPL-1357, and its ability to prompt immune responses. The vaccine candidate was developed by researchers at the …
The NIH Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Cell Census Network (BICCN) has unveiled an atlas of cell types and an anatomical neuronal wiring diagram for the mammalian primary motor cortex, derived from detailed studies of mice, monkeys, and humans. This publicly available resource represents the culmination of an international collaborative effort by …
After having COVID-19, most people’s bodies develop antibodies to help fight it off. These are special molecules made by the body’s disease defense system, the immune system. A study found that people with these antibodies were less likely to get COVID-19 again. Researchers looked at more than 3 million people who had an antibody test …
People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months, according to a newly published study from the National Cancer Institute (NCI). This finding may explain why reinfection appears to be relatively …
According to a news release, the National Institutes of Health are enrolling participants who have been hospitalized with COVID-19 to evaluate investigation therapeutics in two large clinical trials. Two randomized, controlled Phase 3 clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with moderate COVID-19. The trials …
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced the clinical investigators and institutions that will lead four NIH HIV clinical trials networks over the next seven years to conduct the innovative, efficient clinical research needed to accelerate progress against the HIV pandemic. NIAID also awarded …
It’s common to worry about things like germs or to double-check that the stove is turned off. But for people with obsessive-compulsive disorder (OCD), these thoughts and behaviors are so severe that they interfere with daily life. OCD is a mental health condition that causes repeated unwanted thoughts, called obsessions. This can trigger compulsions—the urge …
Maybe you’ve noticed that you get out of breath doing light activities lately. Or have a cough that won’t go away. You might think it’s temporary, or just part of getting older. But these issues can also be signs of chronic obstructive pulmonary disease, more commonly called COPD. With COPD, your lungs can no longer …
COVID-19 is presenting many challenges as well as learning opportunities, according to a media advisory, an NIH groundbreaking study is testing a comprehensive model intervention to help reduce opioid overdose deaths in hard-hit communities. This study aims to address gaps in reaching communities that are most heavily affected by the opioid epidemic with proven, evidence-based …